Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (231-240 of 509) with videos related to

Pageof 51
Sort By:
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
AIDS (London, England)|April 19, 2016
Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosineKatherine W Kooij, Ferdinand W N M Wit, Rosan A van Zoest, et al.
Therapeutic Drug Monitoring|September 28, 2007
Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimenSelwyn H Lowe, Elisabeth van Leeuwen, Jacqueline A H Droste, et al.
The Journal of Infectious Diseases|February 6, 2013
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D studyLene Ryom, Amanda Mocroft, Ole Kirk, et al.
Statistical Methods in Medical Research|February 12, 2025
Bayesian mixture models for phylogenetic source attribution from consensus sequences and time since infection estimatesAlexandra Blenkinsop, Lysandros Sofocleous, Francesco Di Lauro, et al.
Archives of Internal Medicine|July 2, 2002
Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the ATHENA cohortJeanne P Dieleman, Miriam C J M Sturkenboom, Marielle Jambroes, et al.
BMC Nephrology|March 27, 2014
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D studyDavid A Kamara, Lene Ryom, Michael Ross, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling StudyMikaela Smit, Rosan A van Zoest, Brooke E Nichols, et al.
Journal of the International AIDS Society|November 14, 2014
A clinically useful risk-score for chronic kidney disease in HIV infectionAmanda Mocroft, Jens Lundgren, Michael Ross, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 27, 2020
Acute hepatitis C infection among adults with HIV in the Netherlands between 2003 and 2016: a capture-recapture analysis for the 2013 to 2016 periodT Sonia Boender, Eline Op de Coul, Joop Arends, et al.
Pageof 51

Showing results (231-240 of 509) with videos related to

Sort By:
Pageof 51
Antiviral Therapy|November 13, 2004
Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA studyCecilia Cabrera, Alessandro Cozzi-Lepri, Andrew N Phillips, et al.
AIDS (London, England)|April 19, 2016
Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosineKatherine W Kooij, Ferdinand W N M Wit, Rosan A van Zoest, et al.
Therapeutic Drug Monitoring|September 28, 2007
Semen quality and drug concentrations in seminal plasma of patients using a didanosine or didanosine plus tenofovir containing antiretroviral regimenSelwyn H Lowe, Elisabeth van Leeuwen, Jacqueline A H Droste, et al.
The Journal of Infectious Diseases|February 6, 2013
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D studyLene Ryom, Amanda Mocroft, Ole Kirk, et al.
Statistical Methods in Medical Research|February 12, 2025
Bayesian mixture models for phylogenetic source attribution from consensus sequences and time since infection estimatesAlexandra Blenkinsop, Lysandros Sofocleous, Francesco Di Lauro, et al.
Archives of Internal Medicine|July 2, 2002
Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the ATHENA cohortJeanne P Dieleman, Miriam C J M Sturkenboom, Marielle Jambroes, et al.
BMC Nephrology|March 27, 2014
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D studyDavid A Kamara, Lene Ryom, Michael Ross, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2017
Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling StudyMikaela Smit, Rosan A van Zoest, Brooke E Nichols, et al.
Journal of the International AIDS Society|November 14, 2014
A clinically useful risk-score for chronic kidney disease in HIV infectionAmanda Mocroft, Jens Lundgren, Michael Ross, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 27, 2020
Acute hepatitis C infection among adults with HIV in the Netherlands between 2003 and 2016: a capture-recapture analysis for the 2013 to 2016 periodT Sonia Boender, Eline Op de Coul, Joop Arends, et al.
Pageof 51